| Comprehensive molecular portraits of human breast tumours Cancer Genome Atlas Network Nature 490 (7418), 61, 2012 | 7129 | 2012 |
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies AH Bild, G Yao, JT Chang, Q Wang, A Potti, D Chasse, MB Joshi, ... Nature 439 (7074), 353-357, 2006 | 2083 | 2006 |
| Predicting the clinical status of human breast cancer by using gene expression profiles M West, C Blanchette, H Dressman, E Huang, S Ishida, R Spang, H Zuzan, ... Proceedings of the National Academy of Sciences 98 (20), 11462-11467, 2001 | 1598 | 2001 |
| BRCA1 mutations in primary breast and ovarian carcinomas PA Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, ... Science 266 (5182), 120-122, 1994 | 1541 | 1994 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 1067 | 2018 |
| Comprehensive molecular portraits of invasive lobular breast cancer G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ... Cell 163 (2), 506-519, 2015 | 1054 | 2015 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 847 | 2018 |
| Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression CK Anders, DS Hsu, G Broadwater, CR Acharya, JA Foekens, Y Zhang, ... Journal of clinical oncology 26 (20), 3324-3330, 2008 | 823 | 2008 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 721 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 655 | 2018 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 633 | 2018 |
| Genomic signatures to guide the use of chemotherapeutics A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ... Nature medicine 12 (11), 1294-1300, 2006 | 632 | 2006 |
| Overexpression and mutation of p53 in epithelial ovarian cancer JR Marks, AM Davidoff, BJ Kerns, PA Humphrey, JC Pence, RK Dodge, ... Cancer research 51 (11), 2979-2984, 1991 | 598 | 1991 |
| Compromised HOXA5 function can limit p53 expression in human breast tumours V Raman, SA Martensen, D Reisman, E Evron, WF Odenwald, E Jaffee, ... Nature 405 (6789), 974-978, 2000 | 569 | 2000 |
| High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer AT Ferguson, E Evron, CB Umbricht, TK Pandita, TA Chan, H Hermeking, ... Proceedings of the National Academy of Sciences 97 (11), 6049-6054, 2000 | 545 | 2000 |
| Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells T Baba, PA Convery, N Matsumura, RS Whitaker, E Kondoh, T Perry, ... Oncogene 28 (2), 209-218, 2009 | 457 | 2009 |
| Artificial neural networks improve the accuracy of cancer survival prediction HB Burke, PH Goodman, DB Rosen, DE Henson, JN Weinstein, ... Cancer 79 (4), 857-862, 1997 | 414 | 1997 |
| BRCA2 mutations in primary breast and ovarian cancers JM Lancaster, R Wooster, J Mangion, CM Phelan, C Cochran, C Gumbs, ... Nature genetics 13 (2), 238-240, 1996 | 408 | 1996 |
| Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. AM Davidoff, JD Iglehart, JR Marks Proceedings of the National Academy of Sciences 89 (8), 3439-3442, 1992 | 380 | 1992 |
| Genetic basis for p53 overexpression in human breast cancer AM Davidoff, PA Humphrey, JD Iglehart, JR Marks Proceedings of the National Academy of Sciences 88 (11), 5006-5010, 1991 | 380 | 1991 |
Joellen SchildkrautEmory University確認したメール アドレス: emory.edu
